AI assistant
Sending…
Disc Medicine, Inc. — Director's Dealing 2021
May 3, 2021
31589_dirs_2021-05-03_60dfe113-efa5-482b-9f17-4fd8fdcfa1da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Gemini Therapeutics, Inc. /DE (GMTX)
CIK: 0001816736
Period of Report: 2021-04-29
Reporting Person: GEMAYEL GEORGES (Director)
More from Disc Medicine, Inc.
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Director's Dealing
2026
Feb 19